New cutting edge technology can be used to grade cancer tumours, eradicating human subjectivity and ensuring patients get the right treatment.
A new imaging technology to grade tumour biopsies has been developed by a team of scientists led by the Department of Physics and the Department of Surgery and Cancer at Imperial College London.
Publishing their results today in the journal Convergent Science Physical Oncology, they describe how their new method promises to significantly reduce the subjectivity and variability in grading the severity of cancers.
[Digistain] is an extremely reliable indicator of the degree of progression of the disease. Because it is based on a physical measurement, rather than a human judgement, it promises to remove the element of chance in cancer diagnosis.Professor Chris Phillips
Nearly all cancers are still diagnosed by doctors taking a sample of the tumour, a so-called biopsy, then slicing it thinly and staining it with two vegetable dyes used for more than 100 years. They look at this ‘H+E stained’ sample under a microscope and then judge the severity of the disease by eye alone.
Life-changing treatment decisions have to be based on this ‘grading’ process, yet it is well known that different practitioners given the same slice will only agree on its grade about 70% of the time, resulting in an overtreatment problem.
The team’s new ‘Digistain’ technology addresses this problem by using invisible mid-infrared light to photograph the tissue slices in a way that maps out the chemical changes that signal the onset of cancer. In particular, they measure the ‘nuclear-to-cytoplasmic-ratio’ (NCR): a recognized biological marker for a wide range of cancers.
Lead author Professor Chris Phillips, from the Department of Physics at Imperial, said: “Our machine gives a quantitative ‘Digistain index’ (DI) score, corresponding to the NCR, and this study shows that it is an extremely reliable indicator of the degree of progression of the disease. Because it is based on a physical measurement, rather than a human judgement, it promises to remove the element of chance in cancer diagnosis. “
In the experiment reported today, the team carried out a double-blind clinical pilot trial using two adjacent slices taken from 75 breast cancer biopsies. The first slice was graded by clinicians as usual, using the standard H+E protocol. It was also used to identify the so-called ‘region of interest’ (RoI), i.e. the part of the slice containing the tumour.
The team then used the Digistain imager to get a DI value averaged over the corresponding RoI on the other, unstained slice, and ran a statistical analysis on the results.
Professor Phillips said: “Even with this modest number of samples, the correlation we saw between the DI score and the H+E grade would only happen by chance 1 time in 1400 trials. The strength of this correlation makes us extremely optimistic that Digistain will be able to eliminate subjectivity and variability in biopsy grading.”
Proving its worth
The NCR factor that Digistain measures is known to be common to a wide range of cancers, as it occurs when the reproductive cell cycle gets disrupted in the tumour and cell nuclei get distorted with rogue DNA. It is likely that in the long run, Digistain could help with the diagnosis of all different types of cancer.
At a practical level, the researchers say that the Digistain imaging technology can easily and cheaply be incorporated into existing hospital labs, and be used by their staff. Professor Philips added: “It’s easy to prove its worth by checking it with the thousands of existing biopsy specimens that are already held in hospital archives. Together these facts will smooth the path into the clinic, and it could be saving lives in only a couple of years.”
The Latest on: Cancer diagnosis
via Google News
The Latest on: Cancer diagnosis
- New Artificial Intelligence System May Help Improve Prostate Cancer Diagnosis on April 18, 2019 at 2:17 am
Newly developed artificial intelligence (AI) system may help radiologists to detect prostate cancer effectively. The system, called FocalNet, helps identify and predict the aggressiveness of the ... […]
- George Alagiah On Feeling 'Guilty' For Using Disabled Loos After Bowel Cancer Diagnosis on April 18, 2019 at 2:09 am
Toilet stigma is a real issue for people with invisible illnesses – in some cases it's stopping them from leaving the house. BBC journalist George Alagiah has opened up about adapting to life with a ... […]
- High-Deductible Health Policies Linked To Delayed Diagnosis And Treatment on April 18, 2019 at 2:05 am
Women with low incomes who had high-deductible insurance plans waited an average of 1.6 months longer for diagnostic breast imaging, 2.7 months for first biopsy, 6.6 months for first early-stage ... […]
- Abby Lee Miller Shares Photo of Shaved Head & Spinal Surgery Scar One Year After Cancer Diagnosis on April 17, 2019 at 8:47 pm
“One year ago today ~ I underwent emergency surgery for an infection in my spine. This mass/tumor choking my spinal cord turned out to be Burkitt Lymphoma,” Abby writes. “I endured ten rounds of chemo ... […]
- ‘Jeopardy’ host Alex Trebek plans to return in September, despite cancer diagnosis on April 17, 2019 at 7:44 pm
“Jeopardy” is readying for its summer break, but longtime host Alex Trebek, who is battling pancreatic cancer, said he looks forward to returning to the popular TV game show September. “I look forward ... […]
- WATCH: ‘Jeopardy’ host Alex Trebek gives update on his progress after pancreatic cancer diagnosis. ‘I’m touched beyond words.’ on April 17, 2019 at 6:37 pm
When Alex Trebek announced in March that he had been diagnosed with stage 4 pancreatic cancer, “Jeopardy!" fans rallied to support him. Trebek vowed to stay on the job, even as he sought treatment — ... […]
- After cancer diagnosis, Jeopardy! host Alex Trebek wraps up 35th season on April 17, 2019 at 5:34 pm
After his cancer diagnosis, Jeopardy! Host Alex Trebek wrapped up taping shows for the 35th season of the show. Trebek has hosted 50 episodes of Jeopardy! since he was diagnosed with stage 4 ... […]
- Jeopardy! Host Alex Trebek Gives Health Update Following Cancer Diagnosis: 'I'm Feeling Good' on April 17, 2019 at 2:55 pm
Jeopardy! host Alex Trebek shocked the world last month when he announced he had been diagnosed with Stage 4 pancreatic cancer. On Wednesday, after wrapping Season 35 of the show, he offered fans an ... […]
- 'Jeopardy!' host Alex Trebek says he's 'feeling good,' thankful for outpouring of support following cancer diagnosis on April 17, 2019 at 1:51 pm
(WXYZ) — "Jeopardy!" host Alex Trebek is "feeling good" following his diagnosis of stage 4 pancreatic cancer, which he announced on March 6. The famed quiz-show host posted an update video on the last ... […]
via Bing News